ABC | Volume 111, Nº5, November 2018

Original Article Serpytis et al Anxiety and depression after myocardial infarction Arq Bras Cardiol. 2018; 111(5):676-683 7. Larsen KK, Agerbo E, Christensen B, Sondergaard J, Vestergaard M. Myocardial infarction and risk of suicide: a population-based case-control study. Circulation. 2010;122(23):2388-93. 8. RoestAM,MartensEJ,Denollet J,de JongeP.Prognosticassociationofanxiety post myocardial infarction with mortality and new cardiac events: a meta- analysis. PsychosomMed. 2010;72(6):563-9. 9. Larsen KK. Depression following myocardial infarction--an overseen complication with prognostic importance. Dan Med J. 2013;60(8):B4689. 10. Feinstein RE, Blumenfield M, Orlowski B, Frishman WH, Ovanessian S. A national survey of cardiovascular physicians’ beliefs and clinical care practices when diagnosing and treating depression in patients with cardiovascular disease. Cardiol Rev. 2006;14(4):164-9. 11. Rugulies R. Depression as a predictor for coronary heart disease. a review and meta-analysis. Am J Prev Med. 2002;23(1):51-61. 12. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52(2):69-77. 13. Carvalho IG, Bertolli ED, Paiva L, Rossi LA, Dantas RA, PompeoDA. Anxiety, depression, resilience and self-esteem in individuals with cardiovascular diseases. Rev Lat Am Enf. 2016;24:e2836. 14. Weissman MM, Bland R, Joyce PR, Newman S, Wells JE, Wittchen HU. Sex differences in rates of depression: cross-national perspectives. J Affect Disord. 1993;29(2-3):77-84. 15. BebbingtonP,DunnG,JenkinsR,LewisG,BrughaT,FarrellM,etal.Theinfluence ofageandsexontheprevalenceofdepressiveconditions:reportfromtheNational SurveyofPsychiatricMorbidity.IntRevPsychiatry.2003;15(1-2):74-83. 16. Lukaviciute L, Navickas P, Navickas A, Grigaitiene J, Ganceviciene R, Zouboulis CC. Quality of life, anxiety prevalence, depression symptomatology and suicidal ideation among acne patients in Lithuania. J Eur Acad Dermatol Venereol. 2017;31(11):1900-6. 17. WHO. World Health Statistics. Monitoring Health for the Sustainable Development Goals. Geneva: WHO Press; 2016.p.62-3. 18. vanMelle JP, de Jonge P, Spijkerman TA, Tijssen JG, Ormel J, van Veldhuisen DJ, et al. Prognostic association of depression followingmyocardial infarction withmortality and cardiovascular events: ameta-analysis. PsychosomMed. 2004;66(6):814-22. 19. Arnold SV, Smolderen KG, Buchanan DM, Li Y, Spertus JA. Perceived stress in myocardial infarction: long-termmortality and health status outcomes. J Am Coll Cardiol. 2012;60(18):1756-63. 20. Bush DE, Ziegelstein RC, Tayback M, Richter D, Stevens S, Zahalsky H, et al. Evenminimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol. 2001;88(4):337-41. 21. Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure- Smith N, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation. 2014;129(12):1350-69. 22. Mendes de Leon CF, Krumholz HM, Seeman TS, Vaccarino V, Williams CS, Kasl SV, et al. Depression and risk of coronary heart disease in elderly men andwomen: NewHaven EPESE, 1982-1991. Established Populations for the EpidemiologicStudiesoftheElderly.ArchInternMed.1998;158(21):2341-8. 23. LarsenKK,ChristensenB,NielsenTJ,VestergaardM.Post-myocardialinfarction anxietyordepressivesymptomsandriskofnewcardiovasculareventsordeath: a population-based longitudinal study. PsychosomMed. 2014;76(9):739-46. 24. Hosseini SH, Ghaemian A, Mehdizadeh E, Ashraf H. Contribution of depression and anxiety to impaired quality of life in survivors of myocardial infarction. Int J Psychiatry Clin Pract. 2014;18(3):175-81. 25. SmeijersL,MostofskyE,ToflerGH,MullerJE,KopWJ,MittlemanMA.Anxiety andanger immediatelypriortomyocardial infarctionand long-termmortality: Characteristics of high-risk patients. J PsychosomRes. 2017;93:19-27. 26. Paine NJ, Bacon SL, Pelletier R, Arsenault A, Diodati JG, Lavoie KL. Do Womenwith anxiety or depression have higher rates of myocardial ischemia duringexercisetestingthanmen?CircCardiovascQualOutcomes.2016;9(2 Suppl 1):S53-61. 27. Halvorsen S, Eritsland J, Abdelnoor M, Holst Hansen C, Risoe C, Midtbo K, et al. Gender differences inmanagement and outcome of acutemyocardial infarctions treated in 2006-2007. Cardiology. 2009;114(2):83-8. 28. Lesperance F, Frasure-Smith N, Talajic M, Bourassa MG. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation. 2002;105(9):1049-53. 29. Engel DF, de Oliveira J, Lopes JB, Santos DB, Moreira ELG, Farina M, et al. Is there an association between hypercholesterolemia and depression? Behavioral evidence from the LDLr(-/-) mouse experimental model. Behav Brain Res. 2016 Sep 15;311:31-8. 30. Gehi A, Haas D, Pipkin S, Whooley MA. Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med. 2005;165(21):2508-13. 31. Di Matteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101-7. 32. Swenson JR. Quality of life in patients with coronary artery disease and the impact of depression. Curr Psychiatry Rep. 2004;6(6):438-45. 33. Rodrigues GH, Gebara OC, Gerbi CC, Pierri H, Wajngarten M. Depression as a clinical determinant of dependence and low quality of life in elderly patients with cardiovascular disease. Arq Bras Cardiol. 2015;104(6):443-9. 34. Frasure-Smith N, Lesperance F, Gravel G, Masson A, Juneau M, Talajic M, et al. Depression and health-care costs during the first year following myocardial infarction. J Psychosom Res. 2000;48(4-5):471-8. 35. Lichtman JH, Bigger JT Jr, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lesperance F, et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the AmericanHeart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation. 2008;118(17):1768-75. 36. HaddadM,Walters P, Phillips R, Tsakok J,Williams P, Mann A, et al. Detecting depression in patients with coronary heart disease: a diagnostic evaluation of the PHQ-9 and HADS-D in primary care, findings from the UPBEAT-UK study. PLoS One. 2013;8(10):e78493. 37. Bunevicius A, Staniute M, Brozaitiene J, Pop VJ, Neverauskas J, Bunevicius R. Screening for anxiety disorders in patients with coronary artery disease. Health Qual Life Outcomes. 2013;11:37. 38. HareDL,ToukhsatiSR,JohanssonP,JaarsmaT.Depressionandcardiovascular disease: a clinical review. Eur Heart J. 2014;35(21):1365-72. 39. Gulliksson M, Burell G, Vessby B, Lundin L, Toss H, Svardsudd K. Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Primary Health Care project (SUPRIM). Arch Intern Med. 2011;171(2):134-40. 40. Carney RM, Blumenthal JA, Catellier D, Freedland KE, Berkman LF, Watkins LL, et al. Depression as a risk factor for mortality after acute myocardial infarction. Am J Cardiol. 2003;92(11):1277-81. 682